DocMorris AG
CHF 15.93-CHF 0.10 (-0.62%)
DocMorris AG’s quoted price sits in the upper half of its reported 52-week range, 3.92% below the high.
SIX · ASCN.SW · CHF
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CHF. Historical prices are not a forecast.
Ascom Holding AG’s quoted price sits in the upper half of its reported 52-week range, 14.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ascom Holding AG’s forward annual dividend is CHF 0.20 per share, paid annual. The forward yield is 3.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Ascom Holding AG’s next earnings report is currently expected on Mar 11, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ascom Holding AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ascom Holding AG, operating globally through its subsidiaries, specializes in providing information and communication technology (ICT) and mobile workflow solutions, primarily for the healthcare industry. Their comprehensive product portfolio features advanced nurse call and patient monitoring systems. This includes teleCARE IP, a multifaceted solution for nurse calls, alerts, messaging, patient tracking, and wander management, alongside Telligence, a dedicated patient response system. Ascom also develops Digistat software to streamline clinical workflows and Unite software, a powerful orchestration platform that seamlessly integrates data and events from diverse source systems, delivering alerts, chats, and tasks to users across various endpoint devices. Furthermore, the company supplies a range of mobile communication tools, such as DECT and VoWiFi handsets, pagers, and IP-DECT solutions. Complementing their technology, Ascom offers extensive services encompassing consulting, implementation, training, support, and maintenance. These solutions cater to a broad spectrum of clients, from acute care hospitals and long-term care facilities to enterprises in sectors like retail, security, and hospitality. The company's headquarters are situated in Baar, Switzerland.
Latest available per-share figures in CHF. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CHF 0.14 |
| CHF 150.20M+2.04% vs estimate |
| Q4 2022 | Mar 7, 2023 | CHF 0.37+22.83% vs estimate | CHF 153.60M0.0% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 15.93-CHF 0.10 (-0.62%)
DocMorris AG’s quoted price sits in the upper half of its reported 52-week range, 3.92% below the high.
CHF 125.00+CHF 1.00 (+0.81%)
IVF Hartmann Holding AG’s quoted price sits in the lower half of its reported 52-week range, 16.67% below the high.
CHF 48.60+CHF 0.40 (+0.83%)
COLTENE Holding AG’s quoted price sits in the lower half of its reported 52-week range, 17.63% below the high.
CHF 15.32-CHF 0.28 (-1.79%)
Santhera Pharmaceuticals Holding AG’s quoted price sits in the upper half of its reported 52-week range, 18.68% below the high.
CHF 9.20+CHF 0.07 (+0.77%)
Newron Pharmaceuticals S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 71.11% below the high.
CHF 3.00+CHF 0.01 (+0.33%)
Molecular Partners AG’s quoted price sits in the lower half of its reported 52-week range, 24.24% below the high.
CHF 1.01-CHF 0.06 (-5.61%)
SHL Telemedicine Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.21% below the high.
CHF 2.89+CHF 0.03 (+0.87%)
Relief Therapeutics Holding AG’s quoted price sits in the lower half of its reported 52-week range, 37.15% below the high.